Crizotinib can overcome acquired resistance to CH5424802: Is amplification of the MET gene a key factor?

Toyokawa Gouji, Seto Takashi, Takenoyama Mitsuhiro, Ichinose Yukito

研究成果: ジャーナルへの寄稿 › レター › 査読

本文言語	英語
ページ（範囲）	e27-e28
ジャーナル	Journal of Thoracic Oncology
巻	9
号	3
DOI	https://doi.org/10.1097/JTO.0000000000000113
出版ステータス	出版済み - 3月 2014
外部発表	はい

!!!All Science Journal Classification (ASJC) codes

@article{edbb4b5a08044d40b546edf0ab17ecd8,

title = "Crizotinib can overcome acquired resistance to CH5424802: Is amplification of the MET gene a key factor?",

author = "Toyokawa Gouji and Seto Takashi and Takenoyama Mitsuhiro and Ichinose Yukito",

year = "2014",

month = mar,

doi = "10.1097/JTO.0000000000000113",

language = "English",

volume = "9",

pages = "e27--e28",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "3",

}

TY - JOUR

T1 - Crizotinib can overcome acquired resistance to CH5424802

T2 - Is amplification of the MET gene a key factor?

AU - Gouji, Toyokawa

AU - Takashi, Seto

AU - Mitsuhiro, Takenoyama

AU - Yukito, Ichinose

PY - 2014/3

Y1 - 2014/3

UR - http://www.scopus.com/inward/record.url?scp=84894553635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894553635&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000113

DO - 10.1097/JTO.0000000000000113

M3 - Letter

C2 - 24518097

AN - SCOPUS:84894553635

VL - 9

SP - e27-e28

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 3

ER -